| Product Name | MF | CAS | Details |
|---|
| Topoisomerase 2 beta antibody | Details |
| 3-Chloro-2-ethylphenol | C8H9ClO | 1227417-88-0 | Details |
| BRAF35 antibody | Details |
| 2-{[4-(4-Bromophenyl)-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid | C15H11BrN4O2S | 893725-79-6 | Details |
| Vinylidene fluoride-trifluoroethylene copolymer | C4H3F5 | 28960-88-5 | Details |
| UK 5099 | C18H12N2O2 | 56396-35-1 | Details |
| Midkine protein | Details |
| 4-Methylquinolin-1-ium-1-olate | C10H9NO | 4053-40-1 | Details |
| 1-Myristoyl-2-Hydroxy-sn-Glyc-3-Phosphatidylethanolamine | C19H40NO7P | 123060-40-2 | Details |
| (5-Amino-6-chloropyridin-3-yl)methanol | C6H7ClN2O | 321845-13-0 | Details |
| Solifenacin impurity C | C31H28N2O | 1534326-81-2 | Details |
| (2E)-3-(3-Methylthiophen-2-yl)prop-2-enoic acid | C8H8O2S | 102696-70-8 | Details |
| 6-Hydroxy-7-methoxydihydroligustilide | C13H18O4 | 210036-09-2 | Details |
| N-[(4-Ethoxyphenyl)methyl]-2,2-dimethoxyethanamine | C13H21NO3 | 1178640-57-7 | Details |
| H-VTKHLNQISQSY-OH | Details |
| N-Ethyl-2-(piperidin-2-yl)acetamide | C9H18N2O | 102308-44-1 | Details |
| 1-(Cyclopropylmethyl)-3-methyl-1H-pyrazol-5-amine | C8H13N3 | 1251255-01-2 | Details |
| 8-Ethoxycarbonylheptyl N,N'-di-O-acetyl-b-chitobioside | Details |
| Human Thalamus Tissue Lysate | Details |
| CCDC76 antibody | Details |
| TMEM176B Blocking Peptide | Details |
| [Ala4]-MBP (1-11) | C49H81N21O17 | Details |
| 5-Methyl-2-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-7-carboxylic acid | C9H6F3N3O2 | 1018143-96-8 | Details |
| 4-Bromo-5-methyl-2,3-dihydro-1H-indol-2-one | C9H8BrNO | 1935366-54-3 | Details |
| 2-(4-Cyclopropyl-1H-pyrazol-1-yl)acetic acid | C8H10N2O2 | 1402411-46-4 | Details |
| 1-(2,6-Dimethylpyrimidin-4-yl)-3-methyl-1H-pyrazol-5-amine | C10H13N5 | 956711-44-7 | Details |
| H-THPHFVIPYR-OH | Details |
| 4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)dibenzofuran | C18H19BO3 | 912824-85-2 | Details |
| Phytic acid | C6H18O24P6 | 83-86-3 | Details |
| 2-Methyl-1-[3-(trifluoromethyl)phenyl]-4,5,6,7-tetrahydro-1H-indol-4-one | C16H14F3NO | 327085-04-1 | Details |
| Amlodipine besilate impurity D oxalate salt | C22H25ClN2O9 | 1216406-90-4 | Details |
| Caesappanin C | C32H32O12 | 1913319-59-1 | Details |
| 2-indol-3-yl-N-(5-methylisoxazol-3-yl)-2-oxoethanamide | C14H11N3O3 | 893783-88-5 | Details |
| (5-Methoxy-1-methyl-1H-1,3-benzodiazol-2-yl)methanamine | C10H13N3O | 1017357-82-2 | Details |
| Ethyl 4-(8-chloro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate | C22H21ClN2O2 | 133330-56-0 | Details |
| 2-(1-Ethoxyethyl)-4-methyl-1,3-thiazole-5-carboxylic acid | C9H13NO3S | 1334146-94-9 | Details |
| 2-Cyclopropyl-2-methylmorpholine | C8H15NO | 1490094-48-8 | Details |
| 2-{[(tert-Butoxy)carbonyl]amino}-4-(diethylamino)butanoic acid | C13H26N2O4 | 1404688-53-4 | Details |
| 3-(5-Methyl-2-oxo-2,3-dihydro-1H-imidazol-1-yl)benzoic acid | C11H10N2O3 | 1197911-98-0 | Details |
| tert-Butyl (3-methoxypyridin-4-yl)carbamate | C11H16N2O3 | 1951428-38-8 | Details |
| LEG2 antibody | Details |
| H-ITLYLK-OH | Details |
| (S)-4-Hydroxy propranolol hydrobromide | C16H22BrNO3 | Details |
| 2-(3-Fluoro-4-methoxyphenyl)-2-oxoethyl 6-cyclopropyl-3-methyl-[1,2]oxazolo[5,4-b]pyridine-4-carboxylate | C20H17FN2O5 | 1061175-49-2 | Details |
| 4-(Aminomethyl)phenyl acetate hydrochloride | C9H12ClNO2 | 1803609-66-6 | Details |
| Dimenhydrinate Related Compound E | C8H9ClN4O2 | 4921-49-7 | Details |
| Feline Leukemia Virus p27 protein | Details |
| 4-Chloro-2-cyclopropyl-5-phenylthieno[2,3-d]pyrimidine | C15H11ClN2S | 1019384-02-1 | Details |
| (2-(4-Chloro-2-methylphenoxy)(3-pyridyl))-N-(2-indol-3-ylethyl)formamide | C23H20ClN3O2 | 946386-62-5 | Details |
| 2-Amino-3-Bromo-6-trifluoromethylpyridine | C6H4BrF3N2 | 1214361-39-3 | Details |
| 4-Bromo-8-chloroisoquinoline | C9H5BrClN | 1215767-86-4 | Details |
| 2-Bromo-1-(6-methoxypyridin-3-yl)ethan-1-one | C8H8BrNO2 | 1186113-51-8 | Details |
| Pelitinib-d6 | C24H17ClD6FN5O2 | 1325223-34-4 | Details |
| 4-Fluoro-2-methylbenzoic acid | C8H7FO2 | 321-21-1 | Details |
| 4-Bromo-3,5-dimethoxybenzoic acid methyl ester | C10H11BrO4 | 26050-64-6 | Details |
| 3-hydrazino-2-((4-methylphenyl)sulfonyl)prop-2-enenitrile | C10H11N3O2S | 68342-61-0 | Details |
| (4-Bromo-2,6-dichlorophenyl)hydrazine hydrochloride | C6H5N2Cl2Br.HCl | 1354951-65-7 | Details |
| N-[4-(2-Chloroacetamido)phenyl]thiophene-2-carboxamide | C13H11ClN2O2S | 895801-52-2 | Details |
| 4-Bromo-7,8-dichloroquinoline | C9H4BrCl2N | 1070879-40-1 | Details |
| KCTD10 antibody | Details |
| MYCi975 | C25H16Cl2F6N2O2 | 2289691-01-4 | Details |
| 4-(Methylsulfamoyl)benzene-1-sulfonyl chloride | C7H8ClNO4S2 | 247186-99-8 | Details |
| 2-(Morpholin-3-yl)propan-2-ol | C7H15NO2 | 1781842-73-6 | Details |
| (2S)-2-[2-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)acetamido]-4-methylpentanoic acid | C23H26N2O5 | 161452-54-6 | Details |
| 1-Methoxy-1-phenylpropan-2-one | C10H12O2 | 7624-24-0 | Details |
| 5-bromo-1,3-dichloroisoquinoline | C9H4BrCl2N | 1215767-89-7 | Details |
| OR2AP1 antibody | Details |
| 6-Fluoroisoquinoline-3-carboxylic acid hydrochloride | C10H7ClFNO2 | 794515-88-1 | Details |
| 3-Chloro-1-methyl-1H-indole-2-carboxylic acid | C10H8ClNO2 | 1043420-84-3 | Details |
| 5-Bromo-2-chloro-4-methylaniline | C7H7BrClN | 1067882-54-5 | Details |
| H-YRPGTVALR^-OH | Details |
| rac-(2R,3S)-3-(Ethoxycarbonyl)pyrrolidine-2-carboxylic acid | 2343964-47-4 | Details |
| 3,4-Dihydro-2H-1,4-benzoxazine-7-carboxamide | C9H10N2O2 | 130091-78-0 | Details |
| H-SDGVAGLYR^-OH | Details |
| Human-monoFITC (PheB1) | Details |
| IFN g Mouse | Details |
| 3-(4-Methylpiperidin-1-yl)propanoic acid hydrochloride | C9H18ClNO2 | 19854-75-2 | Details |
| Fmoc-Cys((R)-2,3-di(palmitoyloxy)-propyl)-OH | C53H83NO8S | 139573-77-6 | Details |
| ARHGAP9 antibody | Details |
| tert-Butyl 2-(4-cyanophenoxy)propanoate | C14H17NO3 | 1461709-09-0 | Details |
| TMPRSS3 antibody | Details |
| 1-(3-Bromophenyl)-3-propoxypropan-2-amine | C12H18BrNO | 1248774-50-6 | Details |
| N,N-Dimethyl(3-pyrrolidinyl)methanamine dihydrochloride | C7H17ClN2 | 208711-42-6 | Details |
| 1-(1H-1,3-Benzodiazol-2-yl)-2-methylpropan-2-amine | C11H15N3 | 39650-66-3 | Details |
| 2-Hydroxy-2-(1-methyl-1H-pyrazol-4-yl)acetic acid | C6H8N2O3 | 1250900-54-9 | Details |
| Commd2 Blocking Peptide | Details |
| 2-(Methoxycarbonyl)-2-azabicyclo[2.2.2]oct-7-ene-6-carboxylic acid | C10H13NO4 | 1822965-71-8 | Details |
| N,N-Dimethylmethanesulfonoimidamide hydrochloride | C3H11ClN2OS | 1955519-56-8 | Details |
| 3-(4-Methyl-1,3-thiazol-2-yl)pyridine | C9H8N2S | 39067-27-1 | Details |
| Pyroglutamylated RFamide Peptide (Human) | Details |
| 4-(3-Pyrrolidinylmethyl)-2-piperazinonedihydrochloride | C9H18ClN3O | 1220021-12-4 | Details |
| 5-Hydrazinyl-2-(2-methylpropyl)-1,3-oxazole-4-carbonitrile | C8H12N4O | 890013-64-6 | Details |
| Dimethyl({1H-pyrrolo[2,3-c]pyridin-3-yl}methyl)amine | C10H13N3 | 25957-73-7 | Details |
| Lanreotide | C56H73N11O12S2 | 2378114-72-6 | Details |
| LCBiot-MPGERGAAGIAGPK-OH | Details |
| Fmoc-Arg(Pmc)-Wang resin (100-200 mesh) | Details |
| SAC antibody | Details |
| Keratin Type II antibody | Details |
| rac-(1R,3S,4S)-3-Amino-4-hydroxycyclopentane-1-carboxylic acid hydrochloride | C6H12ClNO3 | 2243512-26-5 | Details |
| Ganolucidic acid A | C30H44O6 | 98665-21-5 | Details |
| Product Total： Product Page： | ||||
| 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 | ||||